Eagle Pharmaceuticals, Inc.

NJ · United States · Reporting entity ID 100000061359

Total reported 2019–2025

$5.78M

#661 of 2,960 reporting companies — 0% of all reported industry payments

$798K in general payments across 6,140 records, plus $4.99M in research funding across 76 records.

How it breaks down

General payments $797,916

Research funding $4,986,636

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.